HMCIB SPAC 3 (KQ:226340) — Market Cap & Net Worth
Market Cap & Net Worth: HMCIB SPAC 3 (226340)
HMCIB SPAC 3 (KQ:226340) has a market capitalization of $187.64 Million (₩276.89 Billion) as of August 28, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #16916 globally and #650 in its home market, demonstrating a 15.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HMCIB SPAC 3's stock price ₩6600.00 by its total outstanding shares 41952400 (41.95 Million). Check current stock price of HMCIB SPAC 3 for real-time trading data and today's change.
HMCIB SPAC 3 Market Cap History: 2015 to 2026
HMCIB SPAC 3's market capitalization history from 2015 to 2026. Data shows growth from $56.29 Million to $187.64 Million (11.55% CAGR).
Index Memberships
HMCIB SPAC 3 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$231.48 Billion | 0.08% | #224 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$231.48 Billion | 0.08% | #224 of 1384 |
Weight: HMCIB SPAC 3's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HMCIB SPAC 3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HMCIB SPAC 3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 226340 net asset value to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
0.00x
HMCIB SPAC 3's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $56.72 Million | $23.63 Billion | $116.97 Million | 0.00x | 0.48x |
| 2018 | $57.00 Million | $29.23 Billion | $313.44 Million | 0.00x | 0.18x |
| 2019 | $108.32 Million | $47.02 Billion | $5.03 Billion | 0.00x | 0.02x |
| 2020 | $66.67 Million | $36.05 Billion | -$1.92 Billion | 0.00x | N/A |
| 2021 | $63.26 Million | $53.81 Billion | -$3.98 Billion | 0.00x | N/A |
| 2022 | $47.19 Million | $60.72 Billion | $2.00 Billion | 0.00x | 0.02x |
| 2023 | $64.11 Million | $72.91 Billion | -$724.79 Million | 0.00x | N/A |
Competitor Companies of 226340 by Market Capitalization
Companies near HMCIB SPAC 3 in the global market cap rankings as of August 28, 2026. Also see 226340 cash flow metrics for how efficiently the company converts equity into cash flow.
Key companies related to HMCIB SPAC 3 by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #50 globally with a market cap of $338.83 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #99 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #100 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #209 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #50 | Procter & Gamble Company | NYSE:PG | $338.83 Billion | $145.00 |
| #99 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #100 | LOréal S.A. | PA:OR | $204.16 Billion | €387.20 |
| #209 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
HMCIB SPAC 3 Historical Marketcap From 2015 to 2026
Between 2015 and today, HMCIB SPAC 3's market cap moved from $56.29 Million to $ 187.64 Million, with a yearly change of 11.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩187.64 Million | +352.67% |
| 2025 | ₩41.45 Million | +6.42% |
| 2024 | ₩38.95 Million | -39.25% |
| 2023 | ₩64.11 Million | +35.84% |
| 2022 | ₩47.19 Million | -25.39% |
| 2021 | ₩63.26 Million | -5.12% |
| 2020 | ₩66.67 Million | -38.45% |
| 2019 | ₩108.32 Million | +90.02% |
| 2018 | ₩57.00 Million | +0.50% |
| 2017 | ₩56.72 Million | +0.50% |
| 2016 | ₩56.43 Million | +0.25% |
| 2015 | ₩56.29 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 27th, 2026 the market cap of HMCIB SPAC 3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $187.64 Million USD |
| MoneyControl | $187.64 Million USD |
| MarketWatch | $187.64 Million USD |
| marketcap.company | $187.64 Million USD |
| Reuters | $187.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more